tradingkey.logo

Movano Inc

MOVE
13.830USD
+9.060+189.94%
Horário de mercado ETCotações atrasadas em 15 min
11.48MValor de mercado
PerdaP/L TTM

Mais detalhes de Movano Inc Empresa

Movano Inc., doing business as Movano Health, is engaged in developing a suite of healthcare solutions to bring medical-grade data to the forefront of wearables. Its devices deliver data to both customers and enterprises, capturing a comprehensive picture of an individual’s health data and translating it into personalized and intelligent insights. Its product in development is the Evie Ring, which is a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one’s health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It is also developing System-on-a-Chip (SoC) designed specifically for blood pressure or continuous glucose monitoring (CGM) systems.

Informações de Movano Inc

Código da empresaMOVE
Nome da EmpresaMovano Inc
Data de listagemMar 23, 2021
CEODr. John Mastrototaro, Ph.D.
Número de funcionários32
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 23
Endereço6800 Koll Center Parkway
CidadePLEASANTON
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal94566
Telefone14083931209
Sitehttps://movanohealth.com/
Código da empresaMOVE
Data de listagemMar 23, 2021
CEODr. John Mastrototaro, Ph.D.

Executivos da empresa Movano Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. John Mastrototaro, Ph.D.
Dr. John Mastrototaro, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
41.17K
+67.21%
Mr. Michael Aaron Leabman
Mr. Michael Aaron Leabman
Founder, Chief Technology Officer, Director
Founder, Chief Technology Officer, Director
21.62K
--
Mr. Brian Cullinan
Mr. Brian Cullinan
Independent Director
Independent Director
15.15K
+27.97%
Mr. Ruben Caballero
Mr. Ruben Caballero
Independent Director
Independent Director
8.83K
+30.59%
Dr. Shaheen Wirk, M.D.
Dr. Shaheen Wirk, M.D.
Independent Director
Independent Director
6.84K
+43.33%
Mr. Jeremy (J.) Cogan
Mr. Jeremy (J.) Cogan
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jill Schmidt
Ms. Jill Schmidt
IR Contact Officer
IR Contact Officer
--
--
Ms. Emily Wang Fairbairn
Ms. Emily Wang Fairbairn
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. John Mastrototaro, Ph.D.
Dr. John Mastrototaro, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
41.17K
+67.21%
Mr. Michael Aaron Leabman
Mr. Michael Aaron Leabman
Founder, Chief Technology Officer, Director
Founder, Chief Technology Officer, Director
21.62K
--
Mr. Brian Cullinan
Mr. Brian Cullinan
Independent Director
Independent Director
15.15K
+27.97%
Mr. Ruben Caballero
Mr. Ruben Caballero
Independent Director
Independent Director
8.83K
+30.59%
Dr. Shaheen Wirk, M.D.
Dr. Shaheen Wirk, M.D.
Independent Director
Independent Director
6.84K
+43.33%
Mr. Jeremy (J.) Cogan
Mr. Jeremy (J.) Cogan
Chief Financial Officer
Chief Financial Officer
--
--

Detalhamento da receita

Sem dados
Sem dados
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: ter, 19 de ago
Atualizado em: ter, 19 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Appel (Peter A)
7.77%
Mastrototaro (John)
4.93%
Clayton Partners LLC
4.79%
Mairs and Power, Inc.
4.50%
Cogan (Jeremy D.)
4.44%
Outro
73.57%
Investidores
Investidores
Proporção
Appel (Peter A)
7.77%
Mastrototaro (John)
4.93%
Clayton Partners LLC
4.79%
Mairs and Power, Inc.
4.50%
Cogan (Jeremy D.)
4.44%
Outro
73.57%
Tipos de investidores
Investidores
Proporção
Individual Investor
29.65%
Investment Advisor
6.13%
Hedge Fund
5.05%
Investment Advisor/Hedge Fund
3.30%
Venture Capital
0.30%
Research Firm
0.23%
Outro
55.33%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
49
125.47K
15.03%
+1.75K
2025Q2
56
3.25M
46.13%
+457.93K
2025Q1
56
2.83M
40.61%
+410.10K
2024Q4
56
2.31M
34.88%
+869.72K
2024Q3
55
2.03M
30.72%
+612.32K
2024Q2
55
2.06M
31.25%
+706.69K
2024Q1
50
720.48K
20.03%
+1.88K
2023Q4
47
725.57K
20.17%
+32.23K
2023Q3
46
940.36K
29.66%
+64.17K
2023Q2
45
886.33K
28.12%
+52.17K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Appel (Peter A)
648.80K
7.77%
--
--
Aug 26, 2025
Mastrototaro (John)
246.22K
2.97%
--
--
Aug 26, 2025
Clayton Partners LLC
400.00K
4.79%
+256.52K
+178.79%
Jun 30, 2025
Mairs and Power, Inc.
375.34K
4.5%
--
--
Jun 30, 2025
Cogan (Jeremy D.)
236.30K
2.85%
--
--
Aug 26, 2025
Fairbairn (Malcolm P.)
367.57K
4.4%
--
--
Aug 26, 2025
Robert W. Baird & Co. Inc.
218.73K
2.62%
-105.21K
-32.48%
Jun 30, 2025
Leabman (Michael Aaron)
216.16K
2.59%
--
--
Aug 26, 2025
Cullinan (Brian)
118.36K
1.43%
--
--
Aug 26, 2025
Fairbairn Emily Wang
120.29K
1.44%
-367.57K
-75.34%
Aug 26, 2025
Ver Mais

ETFs Relacionados

Atualizado em: qui, 6 de nov
Atualizado em: qui, 6 de nov
Nome
Proporção
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proporção0%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Oct 25, 2024
Merger
15→1
Oct 25, 2024
Merger
15→1
Oct 25, 2024
Merger
15→1
Oct 25, 2024
Merger
15→1
Data
Tipo
Proporção
Oct 25, 2024
Merger
15→1
Oct 25, 2024
Merger
15→1
Oct 25, 2024
Merger
15→1
Oct 25, 2024
Merger
15→1
KeyAI